Medacta Shoulder System: Total Shoulder Arthroplasty
Study summary
This is a post-marketing surveillance on Medacta Shoulder System
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients older than 18 years
* Patient with one of the following diagnosis:
Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty
Exclusion Criteria:
* Patients with malignant diseases (at the time of surgery)
* Patients with proven or suspect infections (at the time of surgery)
* Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
* Patients with known incompatibility or allergy to products materials (at the time of surgery)
Primary outcome measure(s)
Survival rate — 10 years Kaplan Meier method
Trial sites (6)
Facility
City
Region
Status
Clinique du Sport et de Chirurgie Orthopédique
Marcq-en-Barœul
France
Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation
München
Germany
Orthopädie Sonnenhof
Bern
Canton of Bern
Inselspital
Bern
Switzerland
Lindenhofspital
Bern
Switzerland
Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates, Kantonsspital St.Gallen,
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.